Skip to content
Apogee Biotechnology Corporation

Apogee Biotechnology Corporation

  • Welcome
  • News
  • Technology
  • Lead Compound
  • Contact Us / Policies

Update on ABC294640 (opaganib)

Posted bylwm100 March 11, 2020May 20, 2020 Leave a comment on Update on ABC294640 (opaganib)

https://www.redhillbio.com/RedHill/Templates/showpage.asp?DBID=1&LNGID=1&TMID=178&FID=2432&PID=0&IID=13253

Posted bylwm100March 11, 2020May 20, 2020Posted inUncategorized

Post navigation

Previous Post Previous post:
Presentation on ABC294640 (opaganib) for Multiple Myeloma
Next Post Next post:
Opaganib (ABC294640) Successfully Treats Patients with COVID-19 in Israel, Clinical Trial Approved in the U.S.

Leave a comment

Cancel reply

Your email address will not be published. Required fields are marked *

Apogee Biotechnology Corporation, Proudly powered by WordPress.